NCT02510092View on ClinicalTrials.gov

Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Autoimmune DiseasesCoronary Artery Disease
Interventions
DEVICE

Percutaneous coronary intervention with new generation fully resorbable scaffold

Trial Locations (1)

1122

Semmelweis University Heart and Vascular Center, Budapest

All Listed Sponsors
collaborator

University of Debrecen

OTHER

lead

Semmelweis University Heart and Vascular Center

OTHER

NCT02510092 - Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment | Biotech Hunter | Biotech Hunter